Modulation of gene expression profiles by hyperosmolarity and insulin

Cellular Physiology and Biochemistry

Volumn 20, Issue 5, 2007, Pages 369-386

  Schäfer, Christine ^a   Gehrmann, Thor ^a   Richter, Lisa ^a   Keitel, Verena ^a   Köhrer, Karl ^a   Häussinger, Dieter ^a   Schliess, Freimut ^a,b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Cell volume; Cyclins transport; Insulin resistance; Translation

Indexed keywords

BETAINE HOMOCYSTEINE METHYLTRANSFERASE; BILE SALT; CATALASE; COMPLEMENTARY DNA; CYCLIN D1; CYCLIN G1; GROWTH HORMONE RECEPTOR; HEME OXYGENASE 1; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 5; ORNITHINE DECARBOXYLASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 5; STAT3 PROTEIN; STAT5 PROTEIN; TUBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; HEPATOMA CELL; HYPEROSMOLARITY; INSULIN RESPONSE; INSULIN SENSITIVITY; MODULATION; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UNINDEXED SEQUENCE; WESTERN BLOTTING;

EUKARYOTA; RATTUS;

EID: 34548348148     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107522     Document Type: Article

References (49)

1. Häussinger D, Lang F: Cell volume in the regulation of hepatic function: a mechanism for metabolic control. Biochim Biophys Acta 1991;1071:331-350.
2. McManus M, Churchwell KB, Strange K: Regulation of cell volume in health and desease. New Engl J Med 1995;333:1260-1265.
3. Lang F, Busch GL, Ritter M, Völkl H, Waldegger S, Gulbins E: Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247-306.
4. Häussinger D, Kubitz R, Reinehr R, Bode JG, Schliess F: Molecular aspects of medicine: from experimental to clinical hepatology. JMAM 2004;25:221-360.
5. Schliess F, Häussinger D: The cellular hydration state: role in apoptosis and proliferation. Signal Transduction 2005:6;297-302.
6. Newsome WP, Warskulat U, Noé B, Wettstein M, Stoll B, Gerok W, Häussinger D: Modulation of phosphoenplpyruvate carboxykinase levels by the hepatocellular hydration state. Biochem J 1994;304:555-560.
7. Warskulat U, Newsome W, Noé B, Stoll B, Häussinger D: Anisoosmotic regulation of hepatic gene expression. Biol Chem Hoppe Seyler 1996;377:57-65.
8. Quillard M, Husson A, Chedeville A, Fairand A, Lavoinne A: Protein synthesis is involved in the modulation of the level of the phosphoenolpyruvate carboxykinase mRNA by changes in cell volume in isolated rat hepatocytes. FEBS Lett 1998;423:125-128.
9. Waldegger S, Gabrysch S, Barth P, Fillon S, Lang F: h-sgk serine-threonine protein kinase as transcriptional target of p38/MAP kinase pathway in HepG2 human hepatoma cells. Cell Physiol Biochem 2000;10:203-208.
10. Hammermann R, Warskulat U, Häussinger D: Anisoosmotic regulation of the Mi-2 autoantigen mRNA in H4IIE rat hepatoma cells and primary hepatocytes. FEBS Lett 1998;435:21-24.
11. Zhang F, Warskulat U, Wettstein M, Häussinger D: Identification of betaine as an osmolyte in rat liver macrophages (Kupffer cells). Gastroenterology 1996;110:1543-1552.
12. Warskulat U, Wettstein M, Häussinger D: Osmoregulated taurine transport in H4IIE rat hepatoma cells and perfused rat liver. Biochem J 1997;321:683-690.
13. Peters-Regehr T, Bode JG, Kubitz R, Häussinger D: Organic osmolyte transport in quiescent and activated rat hepatic stellate cells (Ito cells). Hepatology 1999;29:173-180.
14. Warskulat U, Weik C, Häussinger D: myo-Inositol is an osmolyte in rat liver macrophages (Kupffer cells) but not in RAW 264.7 mouse macrophages. Biochem J 1997;326:289-295.
15. Schäfer C, Hoffmann L, Heldt K, Lornejad-Schäfer MR, Brauers G, Gehrmann T: Osmotic regulation of betaine homocysteine-S-methyltransferase expression in H4IIE rat hepatoma cells. Am J Physiol Gastrointest Liver Physiol 2007;292:G1089-G1098.
16. Kubitz R, Warskulat U, Schmitt M, Häussinger D: Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes. Biochem J 1999;340:585-591.
17. Warskulat U, Kubitz R, Wettstein M, Stieger B, Meier PJ, Häussinger D: Regulation of bile salt export pump mRNA levels by dexamethasone and osmolarity in cultured rat hepatocytes. Biol Chem 1999;380:1273-1279.
18. Häussinger D, Roth E, Lang F, Gerok W: Cellular hydration state: an important determinant of protein catabolism in health and disease. Lancet 1993;341:1330-1332.
19. Schliess F, Häussinger D: Cell volume and insulin signalling. Int Rev Cytol 2003;225:187-228.
20. Bratusch-Marrain PR, DeFronzo RA: Impairment of insulin-mediated glucose metabolism by hyperosmolality in man. Diabetes 1983;32:1028-1034.
21. Page MM, Alberti KG, Greenwood R, Gumaa KA, Hockaday TD, Lowy C: Treatment of diabetic coma with continuous low-dose infusion of insulin. Br Med J 1974;2:687-690.
22. Waldhäusl W, Kleinberger G, Korn A, Dudczak R, Bratusch-Marrain PR, Nowotny P: Severe hyperglycemia: effects of rehydration on endocrine derangements and blood glucose metabolism. Diabetes 1979;28:577-584.
23. Meier R, Thelen M, Hemmings BA: Inactivation and dephosphorylation of protein kinase Balpha (PKBalpha) promoted by hyperosmotic stress. EMBO J 1998;17:7294-7303.
24. Chen D, Fucini RV, Olson AL, Hemmings BA, Pessin JE: Osmotic shock inhibits insulin signaling by maintaining Akt/protein kinase B in an inactive dephosphorylated state. Mol Cell Biol 1999;19:4684-4694.
25. Schliess F, vom Dahl S, Häussinger D: Insulin resistance by loop diuretics and hyperosmolarity in perfused rat liver. Biol Chem 2001;382:1063-1069.
26. O'Brien RM, Granner DK: Regulation of gene expression by insulin. Physiol Rev 1996;76:1109-1161.
27. Lornejad-Schäfer MR, Schäfer C, Graf D, Häussinger D, Schliess F: Osmotic regulation of insulin-induced mitogenactivated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells. Biochem J 2003;371(Pt 2):609-619.
28. Jedlitschky G, Burchell B, Keppler D: The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem 2000;275:30069-30074.
29. Nielsen HB, Wernersson R, Knudsen S: Design of oligonucleotides for microarrays and perspectives for design of multi-transcriptome arrays. Nucleic Acids Res 2003;31:3491-3496.
30. Battaglia C, Salani G, Consolandi C, Bernardi LR, De BG: Analysis of DNA microarrays by non-destructive fluorescent staining using SYBR green II. Biotechniques 2000;29:78-81.
31. Ratnam S, Wijekoon EP, Hall BN, Garrow TA, Brosnan ME, Brosnan JT: Effects of diabetes and insulin on betaine-homocysteine S-methyltransferase expression in rat liver. Am J Physiol Endocrinol Metab 2005;290:E933-E939.
32. Lornejad-Schäfer MR, Albrecht U, Poppek D, Gehrmann T, Grune T, Bode JG: Osmotic regulation of STAT3 stability in H4IIE rat hepatoma cells. FEBS Lett 2005;579:5791-5797.
33. Orlowski CC, Ooi GT, Brown DR, Yang YW, Tseng LY, Rechler MM: Insulin rapidly inhibits insulin-like growth factorbinding protein-1 gene expression in H4IIE rat hepatoma cells. Mol Endocrinol 1991;5:1180-1187.
34. Cohen DM, Wassermann JC, Gullans SR: Immediate early gene and HSP70 expression in hyperosmotic stress in MDCK cells. Am J Physiol Cell Physiol 1991;261:C594-C601.
35. Schulz WA, Eickelmann P, Hallbrucker C, Sies H, Häussinger D: Increase of beta-actin mRNA upon hypotonic perfusion of perfused rat liver. FEBS Lett 1991;292(1-2):264-266.
36. Theodoropoulos PA, Stournaras C, Stoll B, Markogiannakis E, Lang F, Gravanis A: Hepatocyte swelling leads to rapid decrease of the G-/total actin ratio and increases actin mRNA levels. FEBS Lett 1992;311:241-245.
37. 7 Lundgren DW: Effect of hypotonic stress on ornithine decarboxylase mRNA expression in cultured cells. J Biol Chem 1992;267:6841-6847.
38. Butler AP, Cohn WB, Mar PK, Montgomery RL: Regulation of ornithine decarboxylase mRNA by phorbol esters and insulin in normal and C-kinase-deficient rat hepatoma cells. J Cell Physiol 1991;147:256-264.
39. Häussinger D, Stoll B, vom Dahl S, Theodoropoulos PA, Markogiannakis E, Gravanis A: Effect of hepatocyte swelling on microtubule stability and tubulin mRNA levels. Biochem Cell Biol 1994;72:12-19.
40. Weinstock RS, Messina JL: Vanadate and insulin stimulate gene 33 expression. Biochem Biophys Res Commun 1992;189:931-937.
41. Ji S, Guan R, Frank SJ, Messina JL: Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway. J Biol Chem 1999;274:13434-13442.
42. Harrison EM, McNally SJ, Devey L, Garden OJ, Ross JA, Wigmore SJ: Insulin induces heme oxygenase-1 through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in renal cells. FEBS J 2006;273:2345-2356.
43. Lordnejad MR, Schliess F, Wettstein M, Häussinger D: Modulation of the heme oxygenase HO-1 expression by hyperosmolarity and betaine in primary rat hepatocytes. Arch Biochem Biophys 2001;388:285-292.
44. Wijnholds J, Mol CA, van DL, de HM, Scheffer GL, Baas F: Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci U S A 2000;97(13):7476- 7481.
45. Sadzuka Y, Sugiyama T, Suzuki T, Sonobe T: Enhancement of the activity of doxorubicin by inhibition of glutamate transporter. Toxicol Lett 2001;123(2-3):159-167.
46. Schliess F, Heinrich S, Häussinger D: Hyperosmotic induction of the mitogen-activated protein kinase phosphatase MKP-1 in H4IIE rat hepatoma cells. Arch Biochem Biophys 1998;351:35-40.
47. Baxter RC: Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 2000;278:E967-E976.
48. Thomas GV: mTOR and cancer: reason for dancing at the crossroads? Curr Opin Genet Dev 2006;16:78-84.
49. Häussinger D, Lang F: Cell volume and hormone action. Trends Pharmacol Sci 1992;1:371-373.